Treatment of heavily pre-treated metastatic breast cancer with Eribulin: first local experience in Sabah
There are many options in the treatment of heavily pretreated metastatic breast cancer however none of the therapeutic agents have shown promising improvement of survival with good toxicity profile. Eribulin is a novel nontaxane microtubule dynamics inhibitor. Two recent clinical trial showed that E...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Journal |
| Published: |
Medical Journal of Malaysia, Malaysian Medical Association
2016
|
| Subjects: | |
| Online Access: | http://www.myjurnal.my/public/article-view.php?id=103721 |